Abstract: A piezoelectric composite material is formed from a cellulosic material and an inorganic piezoelectric material dispersed in a piezoelectric polymer. The piezoelectric polymer of the composite material has a dielectric constant of from 10 or more. A method of making a piezoelectric is also disclosed wherein a matrix of a cellulosic material, an inorganic piezoelectric material, and a piezoelectric polymer material is formed. The matrix is formed into a piezoelectric composite body.

Abstract: A method for treating endometrial cancer comprising: administering to a patient a cannabis extract (CE) wherein the cannabis extract comprises cannabidiol (CBD) at between 50% and 99% by weight of the CE.

Abstract: Piezoelectric composites are described. A piezoelectric composite can include a polymeric matrix, piezoelectric additive(s), and polyol. Methods of making and using the piezoelectric composite are also described.

Abstract: A controller area network (CAN) node is described for determining a bus load on a CAN bus. An indication of a time window duration of a time window is received by the CAN node and a start time for determining a bus load and an end time based on the start time and the time window duration is defined. The bus load is based on determining whether the CAN bus is active for each bit of one or more bits detected on the CAN bus between the start time and the end time. The bus load is compared to a threshold range. A signal is sent to a host processor if the bus load exceeds or falls below the threshold range.

Abstract: Disclosed herein are methods for treating estrogen sensitive disease, specifically toward endometrial cancers, and compositions used to treat the estrogen sensitive disease. Methods for treating estrogen sensitive diseases comprise administering to a patient an effective amount of a Cannabis extract in the presence of an elevated level of estrogen wherein the estrogen is endogenous estrogen or further comprises exogenous estrogen and wherein the methods may further comprise the addition of a chemotherapeutic agent.

Abstract: Methods for treating ovarian cancer comprising: administering to a patient and effective amount of a cannabis extract comprising CBD wherein preferably the cannabis extract is administered via a mucosal formulation.

Abstract: Disclosed herein are methods for treating estrogen sensitive disease, specifically toward endometrial cancers, and compositions used to treat the estrogen sensitive disease. Methods for treating estrogen sensitive diseases comprise administering to a patient an effective amount of a cannabis extract in the presence of an elevated level of estrogen wherein the estrogen is endogenous estrogen or further comprises exogenous estrogen and wherein the methods may further comprise the addition of a chemotherapeutic agent.

Abstract: Compositions and methods of use of treatment of one or more of ovarian cancer, endometrial cancer, head and neck cancer, noncancerous gynecological disorders, and estrogen sensitive cancers, the composition comprising an effective amount of a cannabinoid and a flavonoid wherein the method comprises administering to a patient in need thereof an effective amount of the composition and optionally administering the composition concomitantly with a chemotherapeutic agent.

Abstract: A virtualized controller area network (CAN) system including multiple virtual CAN controllers and a CAN virtual network controller. The CAN virtual network controller includes virtual CAN interfaces, network interfaces, and a configuration controller. Each of the virtual CAN interfaces communicatively links each virtual CAN controller with the network interfaces, which are each configured to communicatively link one or more of virtual CAN controllers into a CAN network. The configuration controller programs any one or more of the network interfaces to communicatively link any one or more of the virtual CAN controllers in each of one or more CAN networks. The configuration controller configures a network interface for virtual communications for implementing a virtual CAN network, or enables a linked physical protocol engine for implementing a physical CAN network. The number of protocol engines needed, if any, may be significantly reduced thereby reducing pin count and silicon area consumption.

Abstract: A method for treating a noncancerous gynecological disorder comprising: administering to a patient an effective amount of composition comprising a cannabis extract comprising cannabidiol (CBD) wherein the composition is preferably administered in a mucosal form, such as intravaginally.

Abstract: Compositions and methods of use of treatment of one or more of ovarian cancer, endometrial cancer, head and neck cancer, noncancerous gynecological disorders, and estrogen sensitive cancers, the composition comprising an effective amount of a cannabinoid and a flavonoid wherein the method comprises administering to a patient in need thereof an effective amount of the composition and optionally administering the composition concomitantly with a chemotherapeutic agent.

Abstract: A controller area network (CAN) node is described for determining a bus load on a CAN bus. An indication of a time window duration of a time window is received by the CAN node and a start time for determining a bus load and an end time based on the start time and the time window duration is defined. The bus load is based on determining whether the CAN bus is active for each bit of one or more bits detected on the CAN bus between the start time and the end time. The bus load is compared to a threshold range. A signal is sent to a host processor if the bus load exceeds or falls below the threshold range.

Abstract: Compositions and methods of use of treatment of one or more of ovarian cancer, endometrial cancer, head and neck cancer, noncancerous gynecological disorders, and estrogen sensitive cancers, the composition comprising an effective amount of a cannabinoid and a flavonoid wherein the method comprises administering to a patient in need thereof an effective amount of the composition and optionally administering the composition concomitantly with a chemotherapeutic agent.

Abstract: A method for treating a noncancerous gynecological disorder comprising: administering to a patient and effective amount of composition comprising a cannabis extract comprising cannabidiol (CBD) wherein the composition is preferably administered in a mucosal form, such as intravaginally.

Abstract: Methods for treating ovarian cancer comprising: administering to a patient and effective amount of a cannabis extract comprising CBD wherein preferably the cannabis extract is administered via a mucosal formulation.

Abstract: Disclosed herein are methods for treating estrogen sensitive disease, specifically toward endometrial cancers, and compositions used to treat the estrogen sensitive disease. Methods for treating estrogen sensitive diseases comprise administering to a patient an effective amount of a cannabis extract in the presence of an elevated level of estrogen wherein the estrogen is endogenous estrogen or further comprises exogenous estrogen and wherein the methods may further comprise the addition of a chemotherapeutic agent.

Abstract: A method for treating endometrial cancer comprising: administering to a patient a cannabis extract (CE) wherein the cannabis extract comprises cannabidiol (CBD) at between 50% and 99% by weight of the CE.

Abstract: Methods for treating ovarian cancer comprising: administering to a patient and effective amount of a cannabis extract comprising CBD wherein preferably the cannabis extract is administered via a mucosal formulation.

Abstract: A method for treating endometrial cancer comprising: administering to a patient a cannabis extract (CE) wherein the cannabis extract comprises cannabidiol (CBD) at between 50% and 99% by weight of the CE.

Abstract: A piezoelectric composite material is formed from a cellulosic material and an inorganic piezoelectric material dispersed in a piezoelectric polymer. The piezoelectric polymer of the composite material has a dielectric constant of from 10 or more. A method of making a piezoelectric is also disclosed wherein a matrix of a cellulosic material, an inorganic piezoelectric material, and a piezoelectric polymer material is formed. The matrix is formed into a piezoelectric composite body.